Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Neuroprotective Effect of Naloxone in Inflammation-Mediated Dopaminergic Neurodegeneration

Dissociation from the Involvement of Opioid Receptors

  • Protocol
Drugs of Abuse

Part of the book series: Methods In Molecular Medicine™ ((MIMM,volume 79))

  • 1443 Accesses

Abstract

Historically, the nociceptive/analgesic effect of naturally occurring opiates such as morphine has long been recognized by humans. Advances in research in the last several decades have revealed the existence of the so-called endogenous opioid peptides, can be divided into three classes: dynorphins, enkephalins, and β-endorphins. Contrary to the initial understanding, in addition to the cells of the central nervous system, those of peripheral tissues such as cardiac myocytes and heart tissues also express opioid peptides (1–3). The wide distribution of opioid peptides throughout the body underscores their involvement in a variety of cellular activities including pain regulation, respiration, immune responses, and ion channel activity (4) as well as possibly pathophysiological conditions such as asthma, alcoholism, and eating disorders (5–7).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith, A. P. and Lee, N. M. (1988) Pharmacology of dynorphin. Annu. Rev. Pharmacol. Toxicol. 28, 123–140.

    Article  PubMed  CAS  Google Scholar 

  2. Herz, A. (1993) Opioids, Vol. 1. Springer-Verlag, Berlin.

    Google Scholar 

  3. Barron, B. A. (2000) Cardiac opioids. Proc. Soc. Exp. Biol. Med. 224, 1–7.

    Article  PubMed  CAS  Google Scholar 

  4. Roy, S. and Loh, H. (1996) Effects of opioids on the immune system. Neurochem. Res. 21, 1375–1386.

    Article  PubMed  CAS  Google Scholar 

  5. Groneberg, D. A. and Fischer, A. (2001) Endogenous opioids as mediators of asthma. Pulm. Pharmacol. Ther. 14, 383–389.

    Article  PubMed  CAS  Google Scholar 

  6. Gianoulakis, C. (2001) Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J. Psychiatry Neurosci. 26, 304–318.

    PubMed  CAS  Google Scholar 

  7. Volpicelli, J. R. (2001) Alcohol abuse and alcoholism: an overview. J. Clin. Psychiatry 20, 4–10.

    Google Scholar 

  8. Kieffer, B. L. (1995) Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615–635.

    Article  PubMed  CAS  Google Scholar 

  9. Minami, M. and Satoh, M. (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23, 121–145.

    Article  PubMed  CAS  Google Scholar 

  10. Jordan, B. A., Cvejic, S., and Devi, L. A. (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23, S5–S18.

    Article  PubMed  CAS  Google Scholar 

  11. Knapp, R. J., Malatynska, E., Collins, N., et al. (1995) Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9, 516–525.

    PubMed  CAS  Google Scholar 

  12. Iijima, I., Minamikawa, J-I., Jacobsen, A. E., Brossi, A., and Rice, K. E. (1978) Studies in the (+)-morphinin series-5. Synthesis and biological properties of (+)-naloxone. J. Med. Chem. 21, 398–400.

    Article  PubMed  CAS  Google Scholar 

  13. Marcoli, M., Ricevuti, G., Mazzone, A., Pasotti, D., Lecchini, S., and Frigo, G. M. (1989) A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activation. Int. J. Immunopharmacol. 11, 57–61.

    Article  PubMed  CAS  Google Scholar 

  14. Ward, J., Hall, W., and Mattick, R. P. (1999) Role of maintenance treatment in opioid dependence. Lancet 353, 221–226.

    Article  PubMed  CAS  Google Scholar 

  15. de Zwaan, M. and Mitchell, J. E. (1992) Opiate antagonists and eating behavior in humans: a review. J Clin. Pharmacol. 32, 1060–1072.

    PubMed  Google Scholar 

  16. Anton, R. F. (2001) Pharmacologic approaches to the management of alcoholism. J. Clin. Psychiatry 20, 11–17.

    Google Scholar 

  17. Seidl, E. C. (2000) Promising pharmacological agents in the management of acute spinal cord injury. Pharm. Pract. Manag. 20, 21–27.

    CAS  Google Scholar 

  18. Hosobuchi, T., Baskin, D. S., and Woo, S. K. (1982) Reversal of induced ischemic neurologic deficit in gerbil by the opiate antagonist naloxone. Science 215, 69–71.

    Article  PubMed  CAS  Google Scholar 

  19. Fallis, R. J., Fisher, M., and Lobo, R. A. (1983) A double blind trial of naloxone in the treatment of stroke. Stroke 15, 627–629.

    Google Scholar 

  20. Holaday, J. W. and Macolm, D. S. (1986) Endogenous opioids and their antagonist in endotoxic shock, in 9th International Congress of Infectious and Parasitic Diseases: Bacterial Infection, Antibacterial Chemotherapy (Marget, W., Lang, W., and Gabler-Sanberger, E., eds.), pp. 425–435, Munich.

    Google Scholar 

  21. Chen, C., Cheng, J. F. C., Liao, S. L., Chen, W. Y., Lin, N. N., and Kuo, J. S. (2000) Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci. Lett. 287, 113–116.

    Article  PubMed  CAS  Google Scholar 

  22. Chen, C. J., Liao, S. L., Chen, W. Y., Hong, J. S., and Kuo, J. S. (2001) Cerebral ischemia/reperfusion injury in rat brain: effects of naloxone. NeuroReport 12, 1245–1249.

    Article  PubMed  CAS  Google Scholar 

  23. Napolitano, L. M. (2000) Naloxone therapy in shock: the controversy continues. Crit. Care Med. 28, 887–888.

    Article  PubMed  CAS  Google Scholar 

  24. Stoll, G., Jander, S., and Schroeter, M. (1998) Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56, 149–171.

    Article  PubMed  CAS  Google Scholar 

  25. Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391–397.

    Article  PubMed  CAS  Google Scholar 

  26. del Zoppo, G., Ginis, I., Hallenbeck, J. M., Iadecola, C., Wang, X., and Feuerstein, G. Z. (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 10, 95–112.

    Article  PubMed  Google Scholar 

  27. Vallance, P., Collier, J., and Bhagat, K. (1997) Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 349, 1391–1392.

    Article  PubMed  CAS  Google Scholar 

  28. Mehta, J. L. and Li, D. Y. (1999) Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain? Cardiovasc. Res. 43, 291–299.

    Article  PubMed  CAS  Google Scholar 

  29. Lu, J., Ashwell, K. W., and Waite, P. (2000) Advances in secondary spinal cord injury: role of apoptosis. Spine 25, 1859–1866.

    Article  PubMed  CAS  Google Scholar 

  30. DeLeo, J. A. and Yezierski, R. P. (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90, 1–6.

    Article  PubMed  CAS  Google Scholar 

  31. Tjardes, T. and Neugebauer, E. (2002) Sepsis research in the next millennium: concentrate on the software rather than the hardware. Shock 17, 1–8.

    Article  PubMed  Google Scholar 

  32. McGeer, P. L., Itagaki, S., Boyes, B. E., and McGeer, E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38, 1285–1291.

    PubMed  CAS  Google Scholar 

  33. Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. H., and Brosnan, C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia 7, 75–83.

    Article  PubMed  CAS  Google Scholar 

  34. Raine, C. S. (1994) Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53, 328–337.

    Article  PubMed  CAS  Google Scholar 

  35. Kreutzberg, G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312–318.

    Article  PubMed  CAS  Google Scholar 

  36. Aloisi, F. (1999) The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol. 468, 123–133.

    PubMed  CAS  Google Scholar 

  37. Banati, R. B., Gehrmann, J., Schubert, P., and Kreutzberg, G. W. (1993) Cytotoxicity of microglia. Glia 7, 111–118.

    Article  PubMed  CAS  Google Scholar 

  38. Minghetti, L. and Levi, G. (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54, 99–125.

    Article  PubMed  CAS  Google Scholar 

  39. Streit, W. J., Conde, J. R., and Harrison, J. K. (2001) Chemokines and Alzheimer’s disease. Neurobiol. Aging 22, 909–913.

    Article  PubMed  CAS  Google Scholar 

  40. Gonzalez-Scarano, F. and Baltuch, G. (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219–240.

    Article  PubMed  CAS  Google Scholar 

  41. Boje, K. M. and Arora, P. K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587, 250–256.

    Article  PubMed  CAS  Google Scholar 

  42. Chao, C. C., Hu, S., Ehrlich, L., and Peterson, P. K. (1992) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav. Immun. 9, 355–365

    Article  Google Scholar 

  43. Dawson, V. L. (1995) Nitric oxide: role in neurotoxicity. Clin. Exp. Pharmacol. Physiol. 22, 305–308.

    Article  PubMed  CAS  Google Scholar 

  44. Kong, L. Y., Wilson, B. C., McMillian, M. K., Bing, G., Hudson, P. M., and Hong, J. S. (1996) The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol. 172, 77–83.

    Article  PubMed  CAS  Google Scholar 

  45. Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., and Peterson, P. K. (1995) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736–2741.

    Google Scholar 

  46. Jeohn, G-H., Kong, L-Y., Wilson, B., Hudson, P., and Hong, J-S. (1998) Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J. Neuroimmunol. 85, 1–10.

    Article  PubMed  CAS  Google Scholar 

  47. McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J., and Carvey, P. M. (2001) Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp. Neurol. 169, 219–230.

    Article  PubMed  CAS  Google Scholar 

  48. Kong, L. Y., Maderdrut, J. L., Jeohn, G. H., and Hong, J. S. (1999) Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide. Neuroscience 91, 493–500.

    Article  PubMed  CAS  Google Scholar 

  49. Kong, L. Y., Jeohn, G. H., Hudson, P. M., Du, L., Liu, B., and Hong, J. S. (2000) Reduction of lipopolysaccharide-induced neurotoxicity in mouse mixed cortical neuron/glia cultures by ultralow concentrations of dynorphins. J. Biomed. Sci. 7, 241–247.

    Article  PubMed  CAS  Google Scholar 

  50. Jeohn, G. H., Wilson, B., Wetsel, W. C., and Hong, J. S. (2000) The indolocarbazole Go6976 protects neurons from lipopolysaccharide/interferon-gamma-induced cytotoxicity in murine neuron/glia co-cultures. Brain Res. Mol. Brain Res. 79, 32–44.

    Article  PubMed  CAS  Google Scholar 

  51. Liu, B., Qin, L., Yang, S-N., Wilson, B. C., Liu, Y., and Hong, J. S. (2001) Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J. Pharmacol. Exp. Ther. 298, 1133–1141.

    PubMed  CAS  Google Scholar 

  52. Araki, E., Forster, C., Dubinsky, J. M., Ross, M. E., and Iadecola, C. (2001) Cyclo-oxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 32, 2370–2375.

    Article  PubMed  CAS  Google Scholar 

  53. Chang, R. C., Hudson, P., Wilson, B., et al. (2000) Immune modulatory effects of neural cell adhesion molecules on lipopolysaccharide-induced nitric oxide production by cultured glia. Brain Res. Mol. Brain Res. 81, 197–201.

    Article  PubMed  CAS  Google Scholar 

  54. Chang, R. C., Chen, W., Hudson, P., Wilson, B., Han, D. S., and Hong, J. S. (2001) Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J. Neurochem. 76, 1042–1049.

    Article  PubMed  CAS  Google Scholar 

  55. Vawter, M. P., Dillon-Carter, O., Tourtellotte, W. W., Carvey, P., and Freed, W. J. (1996) TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson’s disease in ventricular cerebrospinal fluid. Exp. Neurol. 142, 313–322.

    Article  PubMed  CAS  Google Scholar 

  56. Cassarino, D. S., Fall, C. P., Swerdlow, R. H., et al. (1997) Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson’s disease. Biochim. Biophys. Acta 1362, 77–86.

    PubMed  CAS  Google Scholar 

  57. Banati, R. B., Daniel, S. E., and Blunt, S. B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov. Disord. 13, 221–227.

    Article  PubMed  CAS  Google Scholar 

  58. Hunot, S., Dugas, N., Faucheux, B., et al. (1999) Fc epsilonRII/CD23 is expressed in Parkinson’s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440–3447.

    PubMed  CAS  Google Scholar 

  59. Ravenholt, R. T. and Foege, W. H. (1982) 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 8303, 860–864.

    Article  Google Scholar 

  60. Factor, S. A., Sanchez-Ramos, J., and Weiner, W. J. (1988) Trauma as an etiology of parkinsonism: a historical review of the concept. Mov. Disord. 3, 30–36.

    Article  PubMed  CAS  Google Scholar 

  61. Mattock, C., Marmot, M., and Stern, G. (1998) Could Parkinson’s disease follow intrauterine influenza? a speculative hypothesis. J. Neurol. Neurosurg. Psychiatry 51, 753–756.

    Article  Google Scholar 

  62. Williams, D. B., Annegers, J. F., Kokmen, E., O’Brien, P. C., and Kurland, L. T. (1991) Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurology 41, 1554–1557.

    PubMed  CAS  Google Scholar 

  63. Casals, J., Elizan, T. S., and Yahr, W. H. (1998) Postencephalitic parkinsonism—a review J. Neural. Transm. 105, 645–676.

    Article  PubMed  CAS  Google Scholar 

  64. Plassman, B. L., Havlik, R. J., Steffens, D. C., et al. (2000) Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias. Neurology 55, 1158–1166.

    PubMed  CAS  Google Scholar 

  65. Bronstein, D. M., Perez-Otano, I., Sun, V., et al. (1995) Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704, 112–116.

    Article  PubMed  CAS  Google Scholar 

  66. Castano, A., Herrera, A. J., Cano, J., and Machado, A. (1998) Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrastriatal dopaminergic system. J. Neurochem. 70, 1584–1592.

    Article  PubMed  CAS  Google Scholar 

  67. Liu, B., Jiang, J. W., Wilson, B. C., et al. (2000) Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J. Pharmacol. Exp. Ther. 295, 125–132.

    PubMed  CAS  Google Scholar 

  68. Lu, X., Bing, G., and Hagg, T. (2000) Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 97, 285–291.

    Article  PubMed  CAS  Google Scholar 

  69. Liu, B., Du, L., and Hong, J. S. (2000) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 293, 607–617.

    PubMed  CAS  Google Scholar 

  70. Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309–6316.

    PubMed  CAS  Google Scholar 

  71. Dunwiddie, T. V., Perez-Reyes, E., Rice, K. C., and Palmer, M. R. (1982) Stereoselectivity of opiate antagonists in rat hippocampus and neocortex: responses to (+) and (−) isomers of naloxone. Neuroscience 7, 1691–1702.

    Article  PubMed  CAS  Google Scholar 

  72. Kim, J. P., Goldberg, M. P., and Choi, D. W. (1987) High concentrations of naloxone attenuate N-methyl-d-aspartate receptor-mediated neurotoxicity. Eur. J. Pharmacol. 138, 133–136.

    Article  PubMed  CAS  Google Scholar 

  73. Chatterjie, N., Alexander, G. J., Sechzer, J. A., and Lieberman, K. W. (1996) Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity. Neurochem. Res. 21, 691–693.

    Article  PubMed  CAS  Google Scholar 

  74. Chatterjie, N., Sechzer, J. A., Lieberman, K. W., and Alexander, G. J. (1998) Dextro-naloxone counteracts amphetamine-induced hyperactivity. Pharmacol. Biochem. Behav. 59, 271–274.

    Article  PubMed  CAS  Google Scholar 

  75. Simpkins, C. O., Ives, N., Tate, E., and Johnson, M. (1985) Naloxone inhibits superoxide release from human neutrophils. Life Sci. 37, 1381–1386.

    Article  PubMed  CAS  Google Scholar 

  76. Simpkins, C. O., Alailima, S. T., and Tate, E. A. (1986) Inhibition by naloxone of neutrophil superoxide release: a potentially useful antiinflammatory effect. Circ. Shock 20, 181–191.

    PubMed  CAS  Google Scholar 

  77. Tariot, P. N., Upadhyaya, A., Sunderland, T., et al. (1999) Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer’s disease and age-matched controls. Biol. Psychiatry 46, 412–419.

    Article  PubMed  CAS  Google Scholar 

  78. Tariot, P. N., Gross, M., Sunderland, T., Weingartner, H., Murphy, D. L., and Cohen, R. M. (1988) High-dose naloxone in older normal subjects: implications for Alzheimer’s disease. J. Am. Geriatr. Soc. 36, 681–686.

    PubMed  CAS  Google Scholar 

  79. Serby, M., Resnick, R., Jordan, B., Adler, J., Corwin, J., and Rotrosen, J. P. (1986) Naltrexone and Alzheimer’s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 10, 587–590.

    Article  PubMed  CAS  Google Scholar 

  80. Henderson, V. W., Roberts, E., Wimer, C., et al. (1989) Multicenter trial of naloxone in Alzheimer’s disease. Ann. Neurol. 25, 404–406.

    Article  PubMed  CAS  Google Scholar 

  81. Holaday, J. W. and Faden, A. I. (1978) Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 275, 450–451.

    Article  PubMed  CAS  Google Scholar 

  82. Chang, R. C., Rota, C., Glover, R. E., Mason, R. P., and Hong, J. S. (2000) A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy. Brain Res. 854, 224–229.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuropharmacology Section, National Institute of Environmental Health Science, National Institutes of Health, Research Triangle Park, NC

    Bin Liu & Jau-Shyong Hong

Authors
  1. Bin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jau-Shyong Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Pharmacy, University of Missouri-Kansas City, Kansas, USA

    John Q. Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Liu, B., Hong, JS. (2003). Neuroprotective Effect of Naloxone in Inflammation-Mediated Dopaminergic Neurodegeneration. In: Wang, J.Q. (eds) Drugs of Abuse. Methods In Molecular Medicine™, vol 79. Humana Press. https://doi.org/10.1385/1-59259-358-5:43

Download citation

  • DOI: https://doi.org/10.1385/1-59259-358-5:43

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-057-1

  • Online ISBN: 978-1-59259-358-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation